TherapeuticsMD | TXMD - Beneficio Operativo





Beneficio Operativo Cambio Fecha
AbbVie USD 6.72B 1.99B 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Novo Nordisk DKK 5.25B 54.37B 2026-06
Pfizer USD 667M 4.32B 2026-06
TherapeuticsMD USD -1.18M 40K 2024-06